Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Hsien-Kun Chang"'
Autor:
Jason Chia‐Hsun Hsieh, Pin‐Chun Chiang, Tsung‐Min Hung, Yin‐Kai Chao, Yung‐Chia Kuo, Chih‐Tsung Wen, Po‐Jung Su, Meng‐Ting Peng, Huan‐Wu Chen, Hui‐Ling Liu, Hsien‐Kun Chang, Min‐Hsien Wu, Hung‐Ming Wang
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8300-8309 (2021)
Abstract Background The optimal definitive chemotherapy regimen during concurrent chemoradiotherapy (CRT) for patients with advanced esophageal squamous cell carcinoma (ESCC) remains unclear because of conflicting evidence. This study aimed to compar
Externí odkaz:
https://doaj.org/article/2e403fc1c54744b5988cbb4089b73642
Autor:
Hsu-Huan Chou, Wen-Ling Kuo, Chi-Chang Yu, Hsiu-Pei Tsai, Shih-Cheh Shen, Chia-Hui Chu, Ming-Chin Yu, Yung-Feng Lo, Muawiya A. Dabora, Hsien-Kun Chang, Yung-Chang Lin, Shir-Hwa Ueng, Shin-Cheh Chen
Publikováno v:
Biomedical Journal, Vol 42, Iss 1, Pp 66-74 (2019)
Background: Neoadjuvant chemotherapy (NAC) is the standard approach for downstaging of locally advanced breast cancer and can improve breast conservation rates. A pathological complete response (pCR) after NAC associated with favorable long-term outc
Externí odkaz:
https://doaj.org/article/c12bedf2d7cc43ea8a1df4acc27aa25e
Autor:
Sung-Bae Kim, Hope S Rugo, Sara A Hurvitz, Hong-Tai Chang, Chiun-Sheng Huang, Su-Hua Lee, Jung-Tung Hung, Shir-Hwa Ueng, Shin-Cheh Chen, Alice L Yu, Ling-Ming Tseng, Louis W C Chow, Ming-Feng Hou, Richard B Schwab, James L Murray, Hsien-Kun Chang, Chwen-Cheng Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Purpose This randomized, double-blind, placebo-controlled, parallel-group, phase II trial assessed the efficacy and safety of adagloxad simolenin (OBI-822; a Globo H epitope covalently linked to keyhole limpet hemocyanin (KLH)) with adjuvant OBI-821
Externí odkaz:
https://doaj.org/article/6edfc74c39b5454884784f7a49c0a626
Publikováno v:
Journal of Cancer Research and Practice, Vol 3, Iss 3, Pp 69-72 (2016)
Background: Adherence to and tolerance of oral adjuvant endocrine therapy (ET) are important to improve survival for hormone receptor (HR)-positive breast cancer patients. To date, there has been limited literature discussing this issue in elderly pa
Externí odkaz:
https://doaj.org/article/4014743a608d477d8c49eeb35e8b175a
Publikováno v:
Journal of the Formosan Medical Association, Vol 115, Iss 4, Pp 249-256 (2016)
Extended hormonal therapy with tamoxifen for > 5 years has improved disease-free survival (DFS) and overall survival (OS) in hormone receptor (HR)-positive breast cancer patients. The aim of this study was to identify the HR-positive breast cancer wo
Externí odkaz:
https://doaj.org/article/ed6c8384701f455fa44071a1ec245d41
Autor:
Chia-Hui Chu, Ren-Chin Wu, Wen-Chi Shen, Shin-Cheh Chen, Wen-Lin Kuo, Chi-Chang Yu, Shir-Hwa Ueng, Hsiu-Pei Tsai, Shih-Che Shen, Yung-Chang Lin, Yung-Feng Lo, Hsien-Kun Chang, Yi-Ting Huang, Hsu-Huan Chou
Publikováno v:
Journal of Cancer
Few studies have analyzed the discrepancy between breast pathologic complete response (B-pCR) and axillary node pCR (N-pCR) rates and their impact on survival outcomes in different intrinsic subtypes of early breast cancer after neoadjuvant chemother
Autor:
Chia-Hsun Hsieh, Cheng-lung Hsu, Cheng-Hsu Wang, Chaung-Chi Liaw, Jen-Shi Chen, Hsien-Kun Chang, Tsai-Shen Yang, John Wen-Chen Chang, Yung-Chang Lin, Chi-Ting Liau, Ngan-Ming Tsang, Joseph Tung-Chieh Chang, Shu-Hang Ng, Hung-Ming Wang
Publikováno v:
Biomedical Journal, Vol 36, Iss 5, Pp 229-236 (2013)
Background: This prospective phase II clinical trial evaluated the efficacy and toxicity of cisplatin, oral tegafur-uracil, leucovorin, and mitomycin C in patients with recurrent or metastatic nasopharyngeal carcinoma. Methods: Patients with histolo
Externí odkaz:
https://doaj.org/article/5a18c3115cf74cccbe55314110dd1eed
Autor:
Yin-Kai Chao1, Hsien-Kun Chang2, Chen-Kan Tseng3, Yun-Hen Liu1, Yu-Wen Wen4 ywwen@mail.cgu.edu.tw
Publikováno v:
Diseases of the Esophagus. Feb2017, Vol. 30 Issue 2, p1-8. 8p.
Autor:
Shin-Cheh Chen, Shih-Che Shen, Chi-Chang Yu, Ting-Shuo Huang, Yung-Feng Lo, Hsien-Kun Chang, Yung-Chang Lin, Wen-Ling Kuo, Hsiu-Pei Tsai, Hsu-Huan Chou, Li-Yu Lee, Yi-Ting Huang
Publikováno v:
Cancers
Cancers, Vol 14, Iss 164, p 164 (2022)
Cancers; Volume 14; Issue 1; Pages: 164
Cancers, Vol 14, Iss 164, p 164 (2022)
Cancers; Volume 14; Issue 1; Pages: 164
Simple Summary Very limited studies so far have analyzed the long-term oncologic outcomes of breast cancer patients that developed metachronous isolated supraclavicular nodal metastasis (miSLNM) with no available treatment strategy for the critical i
Autor:
Ming-Chin Yu, Hsiu-Pei Tsai, Yung-Feng Lo, Shih-Cheh Shen, Shir-Hwa Ueng, Hsu-Huan Chou, Shin-Cheh Chen, Chi-Chang Yu, Muawiya A. Dabora, Chia-Hui Chu, Wen-Ling Kuo, Hsien-Kun Chang, Yung-Chang Lin
Publikováno v:
Biomedical Journal, Vol 42, Iss 1, Pp 66-74 (2019)
Biomedical Journal
Biomedical Journal
Background: Neoadjuvant chemotherapy (NAC) is the standard approach for downstaging of locally advanced breast cancer and can improve breast conservation rates. A pathological complete response (pCR) after NAC associated with favorable long-term outc